Charles Schwab Investment Management Inc Cidara Therapeutics, Inc. Transaction History
Charles Schwab Investment Management Inc
- $429 Billion
- Q1 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Cidara Therapeutics, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 26,814 shares of CDTX stock, worth $340,269. This represents 0.0% of its overall portfolio holdings.
Number of Shares
26,814
Previous 26,814
-0.0%
Holding current value
$340,269
Previous $21,000
14.29%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding CDTX
# of Institutions
52Shares Held
22.1MCall Options Held
2.7KPut Options Held
100-
Bvf Inc San Francisco, CA6.86MShares$87.1 Million0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.35MShares$42.5 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.55MShares$32.4 Million0.0% of portfolio
-
Alethea Capital Management, LLC San Diego, CA1.6MShares$20.3 Million1.21% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct1.25MShares$15.9 Million0.0% of portfolio
About Cidara Therapeutics, Inc.
- Ticker CDTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,075,696
- Market Cap $889M
- Description
- Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifu...